PDXliver: a database of liver cancer patient derived xenograft mouse models
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PDXliver: a database of liver cancer patient derived xenograft mouse models
Authors
Keywords
Liver cancer, PDX model, Drug response, Database
Journal
BMC CANCER
Volume 18, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-05-09
DOI
10.1186/s12885-018-4459-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluation of anti-tumorigenic activity of BP3B against colon cancer with patient-derived tumor xenograft model
- (2016) Hye-Youn Kim et al. BMC Complementary and Alternative Medicine
- Metabolic Evaluation of Non–Small Cell Lung Cancer Patient–Derived Xenograft Models Using 18 F-FDG PET: A Potential Tool for Early Therapy Response
- (2016) Silvia Valtorta et al. JOURNAL OF NUCLEAR MEDICINE
- Assessing the TP53 marker type in patients treated with or without neoadjuvant chemotherapy for resectable colorectal liver metastases: A p53 Research Group study
- (2015) N. Pilat et al. EJSO
- Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets
- (2015) Kornelius Schulze et al. NATURE GENETICS
- High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response
- (2015) Hui Gao et al. NATURE MEDICINE
- Patient-derived xenografts for individualized care in advanced sarcoma
- (2014) Justin Stebbing et al. CANCER
- Trans-ancestry mutational landscape of hepatocellular carcinoma genomes
- (2014) Yasushi Totoki et al. NATURE GENETICS
- Establishment and Characterization of 7 Novel Hepatocellular Carcinoma Cell Lines from Patient-Derived Tumor Xenografts
- (2014) Hong Xin et al. PLoS One
- Therapeutic efficacy of 188Re-MN-16ET lipiodol in an animal model of hepatocellular carcinoma
- (2013) Ping-Wun Huang et al. ANNALS OF NUCLEAR MEDICINE
- Patient-Derived Tumor Xenografts: Transforming Clinical Samples into Mouse Models
- (2013) D. Siolas et al. CANCER RESEARCH
- Somatic changes in primary liver cancer in Russia: A pilot study
- (2013) Olga Kalinina et al. MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
- Suppression of tumor proliferation and angiogenesis of hepatocellular carcinoma by HS-104, a novel phosphoinositide 3-kinase inhibitor
- (2012) Kyung Hee Jung et al. CANCER LETTERS
- Patient-derived tumour xenografts as models for oncology drug development
- (2012) John J. Tentler et al. Nature Reviews Clinical Oncology
- A Validated Tumorgraft Model Reveals Activity of Dovitinib Against Renal Cell Carcinoma
- (2012) S. Sivanand et al. Science Translational Medicine
- Molecularly Targeted Therapy for Advanced Hepatocellular Carcinoma in 2012: Current Status and Future Perspectives
- (2012) Andrew X. Zhu SEMINARS IN ONCOLOGY
- Primary resistance to cetuximab in a panel of patient-derived tumour xenograft models: Activation of MET as one mechanism for drug resistance
- (2011) Rebekka Krumbach et al. EUROPEAN JOURNAL OF CANCER
- A Pilot Clinical Study of Treatment Guided by Personalized Tumorgrafts in Patients with Advanced Cancer
- (2011) M. Hidalgo et al. MOLECULAR CANCER THERAPEUTICS
- Specific TP53 mutations predict aggressive phenotype in head and neck squamous cell carcinoma: a retrospective archival study
- (2011) Jenni K Peltonen et al. Head and Neck Optical Diagnostics Society
- Integrative Transcriptome Analysis Reveals Common Molecular Subclasses of Human Hepatocellular Carcinoma
- (2009) Y. Hoshida et al. CANCER RESEARCH
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started